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Copyright © 2008 AHC Hypermethylation-dependent silencing of the gene is achieved by recruiting methyl-CpG
binding proteins (MeCPs). Among the MeCPs, MeCP2 is the most abundantly and ubiqui-
tously expressed in various types of cells. We first screened the distribution and expression
pattern of MeCP2 in adult and developing rat tissues and found strong MeCP2 expression,
albeit rather ubiquitously among normal tissues, in ganglion cells and intestinal epithelium
in the small intestine, in Purkinje cells and neurons in the brain, in spermatogonia and in epi-
thelial cells in the epididymal duct of the testis. We then assessed the expression and the
methylation pattern of the promoter region of cyclin D1 by immunohistochemistry and sodi-
um bisulfite mapping, and found that cyclin D1 expression in the epididymal duct decreased
rapidly during rat development: strong in newborn rats and very weak or almost negative in
7-day-old rats. Mirroring the decrease of cyclin D1 expression, methylated cytosine at both
CpG and non-CpG loci in the cyclin D1 promoter was frequently observed in the epididymal
duct of 7-day-old rats but not in that of newborn rats. Interestingly, MeCP2 expression also
increased concomitant with the increase of methylation. Cyclin D1 expression in the epi-
didymal duct may be efficiently regulated by the epigenetic mechanism of the cooperative
increase of MeCP2 expression and promoter methylation.
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I. Introduction
After replication, mammalian DNA is marked by the
addition of methyl groups to certain cytosine bases that are
almost exclusively in sequence with CpG [9]. CpG methyla-
tion is involved in the long-term silencing or inactivation of
genes during mammalian development, tumorigenesis and
aging [14]. The mechanism of gene silencing by methylated
cytosine varies among promoters [2, 6]: direct interference
of the binding of the transcription factors by methylated
cytosine or indirect interference by recruiting methyl-CpG-
binding proteins (MeCPs). The precise mechanism of gene
silencing by MeCPs in mammalian cells is either by non-
specifically binding to the methyl-CpG [15] to prevent the
transcriptional factors like Sp1 from DNA binding [11] or
by altering the chromatin structure by recruiting histone-
modifying enzymes [12, 16]. Among MeCPs, MeCP2, the
mutation of which is known to cause Rett’s syndrome [1, 13,
20], is most abundantly expressed as a chromosomal protein
and requires a single methylated CpG site for preferential
binding to DNA [5, 15].
Although MeCP2 is an essential protein ubiquitously
transcribed in all tissues [13, 18], we have previously found
that the level of MeCP2 mRNA expression is not equal in all
colorectal cancer cells [3], and that silencing of E-cadherin
expression requires both promoter hypermethylation and a
significant amount of MeCP2 expression. The exact physio-
logical role of such cooperative and coordinated change of
promoter hypermethylation and MeCP2 expression in nor-Darwanto et al. 136
mal tissues is, however, currently largely unknown.
In this study, to investigate the expression profile of the
MeCP2 gene and the epigenetic mechanism that regulates
rat cyclin D1 expression in normal rat tissues, we analyzed
the level of MeCP2 expression by in situ hybridization and
the methylation status of the rat cyclin D1 gene promoter
with the use of microdissected samples from corresponding
cells by sodium bisulfite mapping. We focused especially
on CpG methylation of the cyclin D1 gene promoter and
MeCP2 expression in the testis of developing rats.
II. Materials and Methods
Tissue preparation
Sprague-Dawley rats were obtained from our breeding
colony. Newborn, 7-day-old and 12-month-old male rats
were decapitated, and tissue samples were removed, fixed
with 4% paraformaldehyde and embedded in paraffin. All
animal experimental procedures were conducted according
to the Guidelines for Animal Experimentation at Kobe Uni-
versity School of Medicine.
Immunohistochemistry
Paraffin-embedded tissues were cut and dewaxed
through a series of graded alcohol. After antigen retrieval by
microwave irradiation (citrate, pH 6) for 10 min, endoge-
nous peroxidase activity was blocked with 3% H2O2 in meth-
anol for 10 min. The specimens were then incubated with
2% non-fat dry milk in phosphate-buffered saline (PBS) for
10 min and with primary antibodies against cyclin D1
(human, rat, and mouse reactive, Zymed Laboratories Inc.,
South San Francisco, CA, USA) for 15 min. After three 10-
min washes with PBS, the specimens were incubated with
rabbit anti-mouse IgG antibody preabsorbed with normal rat
serum. Finally, the cyclin D1 protein was immunolocalized
by the streptavidine-biotin peroxidase complex method.
Microdissection, bisulfite mapping and quantitative real time 
reverse transcriptase (RT)-polymerase chain reaction (PCR)
The methylation status of the rat cyclin D1 gene pro-
moter was analyzed by sodium bisulfite mapping with the
use of microdissected mouse cartilagenous tissue. Seven-
mm-thick sections were cut from formalin-fixed and paraf-
fin-embedded thin sections and stained with HE. The laser
capture microdissection system (LM200, Olympus, Tokyo,
Japan) was used to select cells. Three independent micro-
dissected samples from each part were analyzed by sodium
bisulfite mapping. Dissected samples were lysed overnight
in 25 ml of lysis solution containing 0.1 mg/ml proteinase K,
10 mM Tris-HCl (pH 8.0), 1 mM EDTA, and 1% Tween 20.
Low-melting agarose beads (3.2%) were formed, and meth-
ylated CpG was analyzed by the sodium bisulfite method as
described [4, 8, 17]. Ten ml of low-melting agarose beads
containing 0.5 mg genomic DNA derived from each part
were formed in mineral oil and denatured with NaOH (final
concentration, 0.1 M). The beads were dipped in 1.5 ml of
freshly prepared bisulfite solution containing 1 mM hydro-
quinone and 3.5 M of NaHSO3 at pH 5. The liquid surface
was sealed with mineral oil, and the samples were incubated
for 20 hr at 50°C under light-protected conditions. The
beads were then washed with Tris-EDTA, desulfonated
with 0.5 N NaOH for 30 min, neutralized with 1 N HCl,
and finally washed with Tris-EDTA. Bead fragments con-
taining approximately up to 0.1 mg DNA were analyzed
by nested PCR using the following sets of primers to cover
the promoter region of the rat cyclin D1 gene:
5'-GTTGATGAAATTGAAAGAAGT-3' (sense) for
first PCR;
5'-ACTTTACAACTTCAACAAAACTCCCCT-3',
(antisense) for first PCR;
5'-GGAGGATTTATTTGGGGAAAGAAG-3' (sense)
for nested PCR;
5'-ACTTTACAACTTCAACAAAACTCCCCT-3',
(antisense) for nested PCR.
The PCR condition was as follows: 30 cycles at 95°C
for 30 sec, 60°C for 30 sec, 72°C for 30 sec, and the elonga-
tion step for 5 min at 72°C. The amplified DNA was cloned
into the TA vector (Invitrogen, Carlsbad, CA, USA), and at
least 10 independent clones were selected and sequenced
using the dideoxy termination method (ABI PRISMTM
Model 310 genetic analyzer; Applied Biosystems, Foster
City, CA, USA).
Preparation of digoxigenin (DIG)-labeled single-stranded 
MeCP2 DNA probe
The single-stranded antisense DNA probe specific for
rat MeCP2 was prepared by polymerase chain reaction
(PCR) as described [7]. A 341-bp cDNA fragment from rat
MeCP2 was obtained by RT-PCR using the following pair
of oligonucleotide primers:
5'-GCAGAGACATCAGAAGGGTC-3': sense;
5'-TTCTTAGGTGGTTTCTGCTC-3': antisense.
The cDNA sequence of purified PCR products was
confirmed by the dideoxy termination method. To prepare
the DIG-labeled single-stranded antisense DNA probe, the
purified PCR product was subjected to unidirectional PCR
with the antisense primer alone in the presence of DIG-
dUTP (digoxigenin DNA labeling mixture; Boehringer
Mannheim, Mannheim, Germany). For negative controls,
the DIG-labeled sense probe was similarly prepared with
sense primer-primed unidirectional PCR.
In situ hybridization (ISH)
After dewaxing in xylene and hydrating through a
series of graded ethanol, the tissue sections were treated
with 2 mg/ml proteinase K (SIGMA, St. Louis, MO, USA)
at 37°C for 10 min, refixed with 4% PFA, acetylated with
100 mM triethanolamine containing 0.25% acetic acid for
10 min, and dehydrated through a series of graded ethanol.
The sections were then incubated in a hybridization medi-
um [10 mM Tris-HCl (pH 7.3), 1 mM EDTA, 600 mM
NaCl, 0.25% sodium dodecyl sulfate, 1×Denhardt’s medi-
um, 50% (v/v) deionized formamide/1 ng/ml probe DNA,
10% dextran sulfate] at 50°C in a moist chamber for 24 hr.Cyclin D1 Promoter Methylation and MeCP2 137
After hybridization, the slides were washed with 5×SSC,
50% deionized formamide/2×SSC, 2×SSC and 0.2×SSC. To
visualize the hybridized probe, the slides were incubated
with alkaline phosphatase (ALP)-conjugated anti-DIG anti-
body (Roche Diagnostics GmbH) for 60 min after blocking
with 0.5% non-fat dry milk in 100 mM Tris-HCl (pH 7.5)
containing 150 mM NaCl (TS buffer) for 30 min. The speci-
mens were then washed twice with TS buffer for 20 min
and immersed briefly in 100 mM Tris-HCl (pH 9.5) con-
taining 100 mM NaCl and 50 mM MgCl2. The colorimetric
reaction was done with NBT/BCIP stock solution (Roche
Diagnostics GmbH) in the dark for 50 min, then stopped
with TE buffer. The slides were mounted with CRYSTAL/
MOUNTTM (Biomeda, Foster City, CA, USA) and analyzed
under a light microscope using the differential interference
contrast system without counterstaining.
Statistical analysis
The intensities of the signal of MeCP2 in epididymal
duct, stromal cells and capillary endothelium of normal
developing testis of (0- and 7-day-old) rats were analyzed
by the one way ANOVA as described [10] to examine
whether there were any statistical differences between the
two groups. Twenty-five high-power fields for each of the
three independent samples were evaluated. Values of P<0.05
were considered significant.
III. Results
MeCP2 expression in normal adult rat intestine, cerebellum 
and testis (Figs. 1 and 2)
Although MeCP2 was ubiquitously expressed in nor-
mal adult rat tissues, the characteristic distribution pattern of
MeCP2 mRNA was observed in the intestine, central ner-
vous system and testis. In the small intestine (Fig. 1A),
besides weak and diffuse expression in almost all kinds of
cells, including infiltrating inflammatory cells, MeCP2 was
present to a greater extent in bases of the mucosal crypt and
mucosal surface epithelial cells (Fig. 1B, arrowheads and
asterisks, respectively). Strong MeCP2 expression was
observed in ganglion cells in the proper muscle (Fig. 1B,
arrows). In the colon (Fig. 1C), weak and diffuse MeCP2
expression was observed in the cytoplasm of goblet cells as
well as in infiltrating inflammatory cells throughout the
colon mucosa, except in ganglion cells (Fig. 1D, arrows)
where the expression was significantly strong. Negative
controls prepared by sense probe did not show any signifi-
cant staining (inserts in Fig. 1B, D). In the adult testis
(Fig. 2A), besides weak and diffuse expression in both germ
cells (pachytene spermatocytes, elongated spermatids, pre-
leptene spermatocytes) within the seminiferous tubules and
in stromal cells, strong MeCP2 expression was observed
among spermatogonia lining the periphery of seminiferous
Fig. 1. Distribution of MeCP2 mRNA expression in adult
rat gastrointestinal tract demonstrated by ISH. A. HE stain-
ing of small intestine. B. ISH for MeCP2 mRNA expres-
sion in small intestine. Besides weak and diffuse
expression in almost all kinds of cells, including infiltrating
inflammatory cells and epithelial cells of the small intes-
tine, strong MeCP2 expression is observed among cells in
transition from proliferating neck cells in the crypt to
mature goblet cells (arrowheads). Strong MeCP2 expres-
sion is also observed in ganglion cells in the proper muscle
(arrows).  C. HE staining of colon mucosa. D. ISH for
MeCP2 mRNA expression in the colon. In contrast to the
small intestine, only weak MeCP2 expression is observed
in the cytoplasm of colon mucosal cells as well as in infil-
trating inflammatory cells throughout the colon mucosa,
except in ganglion cells (arrows) expressing a significantly
high level of MeCP2. Negative controls prepared by sense
probe did not show any significant staining (inserts in B
and D)Darwanto et al. 138
tubules (Fig. 2B, arrows). In the cerebellum (Fig. 2C),
MeCP2 expression was abundantly distributed throughout
the layers with the highest level in Purkinje cells (Fig. 2D,
arrowheads), lower in cells in the molecular layer (Fig. 2D,
arrows) and the lowest in the cortex. Negative controls sense
probe did not show any significant staining (inserts in
Fig. 2B, D).
MeCP2 and cyclin D1 expression in seminiferous tubules of 
normal developing testis of (0- and 7-day-old) rats (Fig. 3)
Starting from the newborn rat testis (Fig. 3A), only
very weak staining of cyclin D1 expression was observed in
a small fraction of Leydig cells (Fig. 3B, arrow), and was
negative in the nuclei or the cytoplasm of primordial germ
cells in the seminiferous tubules of the testis. Weak and
diffuse MeCP2 expression was observed in the cytoplasm
of germ cells in the seminiferous tubules, Leydig stromal
(Fig. 3C, arrows) and endothelial cells (Fig. 3C, arrow-
heads). Similarly, cyclin D1 in the testis of the 7-day-old rat
(Fig. 3D) was almost negative except in a few Leydig cells
in the stroma (Fig. 3E, arrows). Weak MeCP2 expression
was ubiquitously observed in both germ cells and stromal
cells (Fig. 3F, arrows). Negative controls prepared by sense
probe did not show any significant staining (inserts in
Fig. 3C, F). No significant staining was observed in negative
controls prepared by replacing the primary antibody with
non-immunized serum for immunohistochemistry (data not
shown).
MeCP2 and cyclin D1 expression in epididymal duct of 
normal developing testis of (0- and 7-day-old) rats (Fig. 4)
In the epididymal duct of the testis of the newborn (0-
day) rat (Fig. 4A), strong cyclin D1 expression was observed
in the nucleus and cytoplasm of epithelial cells of the duct
(Fig. 4B, arrows). ISH disclosed diffuse MeCP2 expression
among stromal cells (Fig. 4C, arrows), but weak in the cyto-
plasm of epithelial cells of the duct. In the testis of the 7-
day-old rat (Fig. 4D), cyclin D1 expression was markedly
reduced and confined to a few epithelial cells of the duct
(Fig. 4E). MeCP2 was strongly expressed in most of the
cytoplasm of epithelial cells of the duct (Fig. 4F, arrows).
By statistical analysis, while no significant difference of
MeCP2 expression was observed in stromal cells and capil-
lary endothelium between 0- and 7-day-old rat, MeCP2 ex-
pression was significantly (P<0.05) higher in 7-day-old than
that of 0-day-old rat. Negative controls prepared by sense
probe did not show any significant staining (inserts in
Fig. 4C, F). No significant staining was observed in negative
controls prepared by replacing the primary antibody with
non-immunized serum for immunohistochemistry (data not
shown).
Fig. 2. The distribution of MeCP2 mRNA expression in
adult rat testis and cerebellum demonstrated by ISH. A. HE
staining of the adult rat testis. B. ISH for MeCP2 mRNA
expression in the testis. Besides weak and diffuse expres-
sion in germ cells (pachytene primary spermatocytes, elon-
gated spermatids, preleptene primary spermatocytes) in the
seminiferous tubules and in stromal cells, strong MeCP2
expression is observed among spermatogonia lining the
periphery of seminiferous tubules (arrows). Weak MeCP2
expression is observed in early and late spermatids. C. HE
staining of the adult rat cerebellum. D. ISH for MeCP2
mRNA expression in the cerebellum. The intensity of
MeCP2 mRNA expression varies among cell types in the
cerebellum: highest in Purkinje cells (arrowheads), lower
in glial cells in the molecular layer (arrows) and the lowest
in the cortex. Negative controls prepared by sense probe
did not show any significant staining (inserts in B and D).Cyclin D1 Promoter Methylation and MeCP2 139
Mapping methylation status of the rat cyclin D1 promoter by 
sodium bisulfite modification method (Fig. 5)
Numerous CpG loci (vertical bars in Fig. 5A) constitute
a CpG island in the 5'-flanking region of rat cyclin D1 gene.
The cyclin D1 promoter was totally unmethylated in micro-
dissected samples of the epididymal collecting duct of the
newborn rat (Newborn-1, -2 and -3). In the 7-day-old rat,
methylated cytosines were frequently observed in both CpG
and non-CpG loci around CRE and two continuous Sp1-
binding sites (7-days-1, -2 and -3).
IV. Discussion
Transcriptional repression by methyl-CpG is mediated
mainly by MeCPs in a sequence-independent process that
involves changes in histone acetylation levels and in chro-
matin structure [5, 16]. Among the MeCPs, MeCP2 is the
most abundantly expressed in the physiologic condition and
plays a central role in recruiting transcriptional repressors
[5]. Indeed, MeCP2 is expressed rather ubiquitously among
normal tissues [13], albeit some cellular heterogeneity in the
normal brain is observed. In our current study, we screened
the MeCP2 expression status in various normal rat tissues
with the use of ISH, and did find that MeCP2 was ubiqui-
tously transcribed in all the tissues; however, the intensity of
MeCP2 mRNA expression varied among cell types (Figs. 1
and 2). Because MeCP2 expression was high among these
cells soon after mitosis and undergoing terminal differentia-
tion (goblet cells in the crypt and spermatogonia in the testis)
or specially differentiated neurons (ganglion and Purkinje
cells), we speculated that MeCP2 expression was enhanced
in post mitotic cells where the methylcytosine rapidly accu-
Fig. 3. Light micrograph of portions of seminiferous tubules of newborn (0-day) and 7-day-old rats. A. HE staining of seminiferous tubules of
the developing testis of the newborn rat. B. Immunohistochemistry for cyclin D1. Besides periodic positive immunoreactions in a small fraction
of the Leydig cells (arrow), cyclin D1 is negative in the nuclei or the cytoplasm of primordial germ cells in the seminiferous tubules of the testis.
C. ISH for MeCP2 mRNA expression. Weak and diffuse MeCP2 expression is observed in the cytoplasm of germ cells in the seminiferous
tubules, Leydig (arrows) and endothelial cells (arrowheads). D. HE staining of seminiferous tubules of the developing testis of the 7-day-old rat.
E. Immunohistochemistry for cyclin D1. Cyclin D1 expression is almost negative except in a few Leydig cells in the stroma (arrows). F. ISH for
MeCP2 mRNA expression in the testis of the 7-day-old rat. Weak MeCP2 expression is ubiquitously observed in both germ cells and stromal
cells (arrows). Negative controls prepared by sense probe did not show any significant staining (inserts in C and F).Darwanto et al. 140
mulates by de novo methyltransferase. Taken together with
our previous findings [3] in colorectal cancers that the level
of MeCP2 mRNA expression is not equivalent in all colo-
rectal cancer cells, and that silencing E-cadherin expres-
sion takes place where both promoter hypermethylation and
a significant amount of MeCP2 expression are required, we
speculate that a significant amount of MeCP2 expression
must also be required for sufficient and efficient epigenetic
silencing of the genes during normal post-mitotic differenti-
ation.
The testis provides rare opportunities for studying
genes involved in cell cycle regulation, since it contains cells
in both mitosis and meiosis as well as differentiated cells
with little proliferative activity. In the testis, besides the
transition from diploid primordial germ cells to haploid
spermatozoa that require genome-wide reprogramming of
DNA methylation, stage- and epididymal-specific gene ex-
pression also requires unique epigenetic regulation. The pro-
moter region of the cyclin D1 gene, on the other hand, con-
tains multiple cis-acting elements, including binding sites
for activator protein-1 (AP-1), for signal transducers and ac-
tivators of transcription (STAT), for Sp1, and for activating
transcription factor (ATP)/cAMP-responsive element-bind-
ing protein (CREB) [19]. The basic promoter structure of the
5'-regulatory region of the cyclin D1 gene has been demon-
strated as a TATA-less promoter with a CRE and two con-
tinuous Sp1-binding sites through which most of the growth
factors exert their cell proliferative stimuli. We have previ-
ously found that the steady-state expression of cyclin D1 is
epigenetically regulated by the cytosine methylation status
in rat leukemia cell lines [6], in that methylation of both CpG
and non-CpG loci spanning the two continuous Sp1-binding
sites and CRE of the cyclin D1 promoter defines its tran-
scriptional activity. To investigate whether or not a similar
Fig. 4. Light micrograph of portions of the epididymal ducts of newborn (0-day) and 7-day-old rats. A. HE staining of the epididymal ducts of
the newborn rat. B. Immunohistochemistry for cyclin D1. Strong cyclin D1 expression is observed in the nucleus and cytoplasm of epithelial
cells of the duct (arrows). C. ISH for MeCP2 mRNA expression. MeCP2 expression is diffusely observed among stromal cells (arrows), but is
weak in the cytoplasm of epithelial cells of the duct. D. HE staining of the epididymal duct of the 7-day-old rat. E. Immunohistochemistry for
cyclin D1. In the 7-day-old rat, cyclin D1 expression is markedly reduced and confined to a few epithelial cells of the duct (arrows). F. ISH for
MeCP2 mRNA expression of the 7-day-old rat. MeCP2 is strongly expressed in most of the cytoplasm of epithelial cells in the duct (arrows).
Negative controls prepared by sense probe did not show any significant staining (inserts in C and F).Cyclin D1 Promoter Methylation and MeCP2 141
Fig. 5. Mapping methylation status of the epididymal duct of newborn (0-day) and 7-day-old rats by sodium bisulfate modification method. A. A
schematic structure of the rat cyclin D1 promoter region. Numerous CpG loci (bars) constitute a CpG island in the 5'-flanking region of rat
cyclin D1 gene. Sense and antisense primers (arrows) were set to cover the CpG loci located in the basic promoter region. B. DNA extracted
from the collecting duct of epididymal tissues from newborn and 7-day-old rats were subjected to sodium bisulfite modification before PCR
amplification to access more precise information about the methylation status, including the non-CpG locus. All bisulfite sequencing from
microdissected tissue samples from the collecting duct of the newborn rat (Newborn-1, -2 and -3) remained unmethylated. In the 7-day-old rat,
methylated cytosines are frequently seen at both CpG and non-CpG loci around CRE and two continuous Sp1-binding sites. The methylation
status is designated as (black quadrangle) methylated at the CpG locus, (quadrangle) non-methylated at the CpG locus, and (bar) methylated at
the non-CpG locus. Processed sequencing data for part of the cyclin D1 gene promoter of the newborn and the 7-day-old rat are inserted.Darwanto et al. 142
epigenetic mechanism is involved in cyclin D1 expression
during rat testicular tissue development (0- and 7-day-old
rats) and spermatogenesis in adult rats, we first checked
cyclin D1 protein expression by immunohistochemistry.
Unexpectedly, during testicular tissue development, instead
of cells of the germ cell lineage expressing only a nominal
amount of cyclin D1 protein (Fig. 3), epididymal ductal cells
of the newborn rat expressed high levels of cyclin D1
protein, which then rapidly diminished in the 7-day-old rat
(Fig. 4). Consequently, we targeted the molecular mecha-
nism that can be linked to cyclin D1 expression in the epi-
didymal duct. Examination of the methylation status of the
cyclin D1 promoter from microdissected tissue samples
revealed that the silencing of cyclin D1 is correlated with
the accumulation of methyl-cytosine at both the CpG and
non-CpG loci during the development of the epididymal
ducts (Fig. 5). This observation supports our previous obser-
vations that the methylation of both CpG and non-CpG
around the two continuous Sp1-binding sites and the CRE
element of cyclin D1 promoter is an important epigenetic
event [6], and that a coordinated significant increase of
MeCP2 expression is required for the sufficient and effi-
cient epigenetic silencing of the genes.
In conclusion, our data provide a clue for exploring the
regulatory mechanism of MeCP2 expression that signifi-
cantly accelerated soon after the addition of de novo methy-
lation during post-mitotic terminal differentiation.
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